HCA Healthcare highlights promising pediatric CRISPR gene therapy results as expanding specialty car

First published data evaluating gene-editing treatment in children ages 5-11 with inherited blood di

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading heal

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus

TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the pric

Bernstein analyst Lance Wilkes maintains HCA Healthcare (NYSE:HCA) with a Market Perform and lowe

HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, and The Colle

TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the pric

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lo

HCA Healthcare Inc. (NYSE:HCA) reported Q1 earnings in line with expectations. CEO cites dynamic env

Stephens & Co. analyst Raj Kumar maintains HCA Healthcare (NYSE:HCA) with a Overweight and l

Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers

Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and

Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and lowe

HCA Healthcare Q1 2026 revenue hits $19.11B, up 4.3% YoY. Adjusted EPS at $7.15. Company reaffirms f

Nasdaq 100 hit a fresh record as Intel surged 23% on a blowout quarter, while Charter Communications

HCA Healthcare (NYSE:HCA) affirms FY2026 GAAP EPS guidance from $29.10-$31.50 to $29.10-$31.50 vs $3

HCA Healthcare (NYSE:HCA) reported quarterly earnings of $7.15 per share which met the analyst conse

HCA Healthcare, Inc (NYSE: HCA) will release Q1 earnings on April 24. Analysts expect $7.15 per shar

HCA has an annual dividend yield of 0.66% ($3.12 a year). So, how can investors exploit its dividend

https://www.medicaid.gov/federal-policy-guidance/downloads/sho26001.pdf

Murphy and Scanlon unveil a bill to protect healthcare whistleblowers, citing risks from private equ

TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the pric

Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the pri

UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target

JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises th

Argus Research analyst David Toung maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and ra

Jefferies analyst Brian Tanquilut maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the p

Cantor raises its HCA price target to $588, citing strong core growth, stable outlook, a solid balan

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises

UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target

Cantor Fitzgerald analyst Sarah James maintains HCA Healthcare (NYSE:HCA) with a Overweight and r

Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises

Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and

Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and rais